Cargando…
Genomic and Long-Term Transcriptomic Imprints Related to the Daptomycin Mechanism of Action Occurring in Daptomycin- and Methicillin-Resistant Staphylococcus aureus Under Daptomycin Exposure
Daptomycin (DAP) is one of the last-resort treatments for heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) and vancomycin-intermediate S. aureus (VISA) infections. DAP resistance (DAP-R) is multifactorial and mainly related to cell-envelope modifications caused by single-nucleotid...
Autores principales: | Cafiso, Viviana, Stracquadanio, Stefano, Lo Verde, Flavia, De Guidi, Irene, Zega, Alessandra, Pigola, Giuseppe, Stefani, Stefania |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7456847/ https://www.ncbi.nlm.nih.gov/pubmed/32922373 http://dx.doi.org/10.3389/fmicb.2020.01893 |
Ejemplares similares
-
Daptomycin in treatment of Methicillin-resistant Staphylococcus aureus diskitis
por: Parlato, Ciro, et al.
Publicado: (2011) -
Daptomycin susceptibility of methicillin resistant Staphylococcus aureus (MRSA)
por: Kaur, Rajneet, et al.
Publicado: (2012) -
Daptomycin-Nonsusceptible Staphylococcus aureus: The Role of Combination Therapy with Daptomycin and Gentamicin
por: Jiang, Jhih-Hang, et al.
Publicado: (2015) -
Daptomycin approved in Japan for the treatment of methicillin-resistant Staphylococcus aureus
por: Hagihara, Mao, et al.
Publicado: (2012) -
Phenotypic and Genotypic Characterization of Daptomycin-Resistant Methicillin-Resistant Staphylococcus aureus Strains: Relative Roles of mprF and dlt Operons
por: Mishra, Nagendra N., et al.
Publicado: (2014)